TAS1440, a novel reversible LSD1 inhibitor, modulates immunosuppressive population and potentiates the antitumor efficacy of anti-PD-1 antibody therapy

Autor:	T. Shibutani, H. Fukushima, S. Tsukioka, T. Machida, A. Osada, M. Yamada, S. Yamashita, S. Ohkubo
Rok vydání:	2022
Předmět:	Cancer Research Oncology
Zdroj:	European Journal of Cancer. 174:S73
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::82015ce70bc5ecfcee9a1b83667b75b2 https://doi.org/10.1016/s0959-8049(22)00995-9 Zobrazit plný text záznamu Full Text from ScienceDirect